stock
Vyne Therapeutics Inc
NASDAQ | VYNE
0.37
USD
$0.00
(0.00%
)At Close (As of Dec 12, 2025)
$12.50M
Market Cap
-
P/E Ratio
-0.79
EPS
$4.30
52 Week High
$0.28
52 Week Low
HEALTHCARE
Sector
VYNE Chart
Recent Chart
Price Action
VYNE Technicals
VYNE Earnings
Yearly Income Statement (As of Dec 31, 2024)
| Field | Value (USD) |
|---|---|
| Gross Profit | $501K |
| Total Revenue | $501K |
| Cost Of Revenue | $4K |
| Costof Goods And Services Sold | $4K |
| Operating Income | -$44M |
| Selling General And Administrative | $13M |
| Research And Development | $31M |
| Operating Expenses | $44M |
| Investment Income Net | - |
| Net Interest Income | - |
| Interest Income | - |
| Interest Expense | - |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $4K |
| Income Before Tax | -$40M |
| Income Tax Expense | $4K |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$40M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$44M |
| Ebitda | -$44M |
| Net Income | -$40M |
Revenue & Profitability
Earnings Performance
VYNE Financials
yearly Cash Flow (As of Dec 31, 2024)
| Field | Value (USD) |
|---|---|
| Operating Cashflow | -$34M |
| Payments For Operating Activities | - |
| Proceeds From Operating Activities | - |
| Change In Operating Liabilities | - |
| Change In Operating Assets | - |
| Depreciation Depletion And Amortization | $4K |
| Capital Expenditures | $117K |
| Change In Receivables | - |
| Change In Inventory | - |
| Profit Loss | - |
| Cashflow From Investment | $23M |
| Cashflow From Financing | -$141K |
| Proceeds From Repayments Of Short Term Debt | - |
| Payments For Repurchase Of Common Stock | - |
| Payments For Repurchase Of Equity | - |
| Payments For Repurchase Of Preferred Stock | - |
| Dividend Payout | - |
| Dividend Payout Common Stock | - |
| Dividend Payout Preferred Stock | - |
| Proceeds From Issuance Of Common Stock | - |
| Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
| Proceeds From Issuance Of Preferred Stock | - |
| Proceeds From Repurchase Of Equity | -$141K |
| Proceeds From Sale Of Treasury Stock | - |
| Change In Cash And Cash Equivalents | - |
| Change In Exchange Rate | - |
| Net Income | -$40M |
yearly Income Statement (As of Dec 31, 2024)
| Field | Value (USD) |
|---|---|
| Gross Profit | $501K |
| Total Revenue | $501K |
| Cost Of Revenue | $4K |
| Costof Goods And Services Sold | $4K |
| Operating Income | -$44M |
| Selling General And Administrative | $13M |
| Research And Development | $31M |
| Operating Expenses | $44M |
| Investment Income Net | - |
| Net Interest Income | - |
| Interest Income | - |
| Interest Expense | - |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $4K |
| Income Before Tax | -$40M |
| Income Tax Expense | $4K |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$40M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$44M |
| Ebitda | -$44M |
| Net Income | -$40M |
VYNE Profile
Vyne Therapeutics Inc Profile
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Vyne Therapeutics Inc. is a biopharmaceutical company headquartered in Bridgewater, New Jersey, specializing in the development of innovative therapies for dermatological conditions. Leveraging its proprietary technology and therapeutic platforms, Vyne is focused on addressing significant unmet medical needs in skin diseases, which may lead to enhanced treatment outcomes for patients. With a promising pipeline and commitment to improving patient quality of life, Vyne is strategically positioned to become a key player in the biopharmaceutical industry, potentially delivering groundbreaking solutions in dermatology.
LPTX +368.57%
$2.05
PAVS +19.13%
$0.04
OCG -75.85%
$0.22
YCBD +90.17%
$1.20
NVDA -3.26%
$175.02
CGC +53.98%
$1.74
YGMZ -61.42%
$0.02
WOK -35.71%
$0.10
PLUG -1.69%
$2.32
ASST -6.35%
$0.86
RIVN +12.11%
$18.42
TSLA +2.70%
$458.96
AVGO -11.42%
$359.93
ONDS -2.99%
$8.75
INTC -4.30%
$37.81
TLRY +44.12%
$12.15
ATPC -25.11%
$0.13
IQ -4.41%
$1.95
AXDX -61.36%
$0.03
TNYA -37.50%
$0.85
FRMI
-33.83%
$10.09
AKAN +19.53%
$0.94
KAVL -29.95%
$0.14
TE -8.85%
$5.35
ASBP -9.09%
$0.09
ORCL -4.46%
$189.97
SOFI +0.77%
$27.28
VIVK -1.75%
$0.07
BMNR
-9.17%
$34.86
PFE +0.19%
$25.85
ZDGE +14.40%
$2.78
ADAP -15.14%
$0.05
DNN -5.43%
$2.61
HPE -2.73%
$23.87
NFLX +1.16%
$95.19
F +0.95%
$13.76
AAL 0.00%
$14.96
PLTD +2.21%
$6.46
KVUE +0.05%
$17.33
WBD +1.66%
$29.98
VHAI 0.00%
$0.00
WULF -9.47%
$14.33
UGRO +38.07%
$0.33
MARA -2.70%
$11.52
SOND -23.45%
$0.12
PLTR -2.11%
$183.57
RR -11.96%
$4.12
BMNU
-18.78%
$8.30
BYND -7.62%
$1.09
VALE -2.76%
$12.69
BAC +1.06%
$55.14
RMBL +60.50%
$3.21
AAPL +0.08%
$278.28
LNW -3.71%
$86.22
ACHR -3.03%
$8.30
APLT -45.91%
$0.11
SNAP -4.31%
$7.31
ADD -25.47%
$0.05
CLSK -5.33%
$14.03
BITF -6.80%
$2.74
IVP -12.42%
$0.04
AMD -4.80%
$210.78
GOOGL -1.00%
$309.29
AMZN -1.77%
$226.19
IREN -8.67%
$40.13
IRBT -13.60%
$4.32
CRWV
-10.05%
$78.59
BTG -1.70%
$4.60
RZLT +28.57%
$1.80
SRM +53.27%
$10.30
T +1.15%
$24.58
RIG -3.50%
$4.13
RKLB -3.21%
$61.49
QBTS -6.71%
$26.10
NIO -1.94%
$5.03
CVE +1.74%
$18.03
HOOD -3.14%
$119.50
CIFR -9.69%
$17.05
RGTI -3.86%
$25.84
TWOH
-7.69%
$0.00
GRAB -0.57%
$5.15
CAN -9.05%
$0.84
SMR -13.57%
$18.34
BBD +1.17%
$3.45
CMG +3.64%
$36.14
MTSR -0.35%
$70.50
SOUN -3.15%
$11.65
CHR 0.00%
$0.04
ABEV +2.00%
$2.55
MU -6.70%
$241.14
HL -2.79%
$18.81
JBLU +1.02%
$4.94
KIND -14.44%
$2.37
NXDR
-14.44%
$2.37
IBRX +7.76%
$2.36
AG -5.17%
$15.94
NOK -1.41%
$6.27
APLD -9.42%
$27.86
BTBT -8.53%
$2.25
CDE -1.31%
$17.25
LPTX +368.57%
$2.05
PAVS +19.13%
$0.04
OCG -75.85%
$0.22
YCBD +90.17%
$1.20
NVDA -3.26%
$175.02
CGC +53.98%
$1.74
YGMZ -61.42%
$0.02
WOK -35.71%
$0.10
PLUG -1.69%
$2.32
ASST -6.35%
$0.86
RIVN +12.11%
$18.42
TSLA +2.70%
$458.96
AVGO -11.42%
$359.93
ONDS -2.99%
$8.75
INTC -4.30%
$37.81
TLRY +44.12%
$12.15
ATPC -25.11%
$0.13
IQ -4.41%
$1.95
AXDX -61.36%
$0.03
TNYA -37.50%
$0.85
FRMI
-33.83%
$10.09
AKAN +19.53%
$0.94
KAVL -29.95%
$0.14
TE -8.85%
$5.35
ASBP -9.09%
$0.09
ORCL -4.46%
$189.97
SOFI +0.77%
$27.28
VIVK -1.75%
$0.07
BMNR
-9.17%
$34.86
PFE +0.19%
$25.85
ZDGE +14.40%
$2.78
ADAP -15.14%
$0.05
DNN -5.43%
$2.61
HPE -2.73%
$23.87
NFLX +1.16%
$95.19
F +0.95%
$13.76
AAL 0.00%
$14.96
PLTD +2.21%
$6.46
KVUE +0.05%
$17.33
WBD +1.66%
$29.98
VHAI 0.00%
$0.00
WULF -9.47%
$14.33
UGRO +38.07%
$0.33
MARA -2.70%
$11.52
SOND -23.45%
$0.12
PLTR -2.11%
$183.57
RR -11.96%
$4.12
BMNU
-18.78%
$8.30
BYND -7.62%
$1.09
VALE -2.76%
$12.69
BAC +1.06%
$55.14
RMBL +60.50%
$3.21
AAPL +0.08%
$278.28
LNW -3.71%
$86.22
ACHR -3.03%
$8.30
APLT -45.91%
$0.11
SNAP -4.31%
$7.31
ADD -25.47%
$0.05
CLSK -5.33%
$14.03
BITF -6.80%
$2.74
IVP -12.42%
$0.04
AMD -4.80%
$210.78
GOOGL -1.00%
$309.29
AMZN -1.77%
$226.19
IREN -8.67%
$40.13
IRBT -13.60%
$4.32
CRWV
-10.05%
$78.59
BTG -1.70%
$4.60
RZLT +28.57%
$1.80
SRM +53.27%
$10.30
T +1.15%
$24.58
RIG -3.50%
$4.13
RKLB -3.21%
$61.49
QBTS -6.71%
$26.10
NIO -1.94%
$5.03
CVE +1.74%
$18.03
HOOD -3.14%
$119.50
CIFR -9.69%
$17.05
RGTI -3.86%
$25.84
TWOH
-7.69%
$0.00
GRAB -0.57%
$5.15
CAN -9.05%
$0.84
SMR -13.57%
$18.34
BBD +1.17%
$3.45
CMG +3.64%
$36.14
MTSR -0.35%
$70.50
SOUN -3.15%
$11.65
CHR 0.00%
$0.04
ABEV +2.00%
$2.55
MU -6.70%
$241.14
HL -2.79%
$18.81
JBLU +1.02%
$4.94
KIND -14.44%
$2.37
NXDR
-14.44%
$2.37
IBRX +7.76%
$2.36
AG -5.17%
$15.94
NOK -1.41%
$6.27
APLD -9.42%
$27.86
BTBT -8.53%
$2.25
CDE -1.31%
$17.25